Pfizer Exubera Launch May Demonstrate Impact Of Revised DTC Ad Policy

Launch of Pfizer/Sanofi-Aventis' inhaled insulin Exubera could demonstrate the impact of Pfizer's new direct-to-consumer advertising guidelines